Myriad Genetics Inc (MYGN)
9.20 x 1 9.37 x 2
Pre-market by (Cboe BZX)
9.21 -0.52 (-5.34%) 03/26/25 [NASDAQ]
9.20 x 1 9.37 x 2
Pre-market 9.21 unch (unch) 16:00 ET
for Wed, Mar 26th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 837,600 | 753,200 | 678,400 | 690,600 | 0 |
| Cost of Goods | 252,200 | 236,200 | 202,000 | 197,600 | N/A |
| Gross Profit | 585,400 | 517,000 | 476,400 | 493,000 | N/A |
| Operating Expenses | 709,100 | 774,600 | 617,000 | 684,100 | 0 |
| Operating Income | -123,500 | -257,400 | -140,600 | -190,500 | N/A |
| Interest Expense | 2,800 | 2,900 | 3,200 | 6,600 | 0 |
| Other Income | 2,800 | -1,900 | 3,200 | 140,000 | 0 |
| Pre-tax Income | -123,500 | -262,200 | -140,600 | -57,100 | 0 |
| Income Tax | 3,800 | 1,100 | -28,600 | -29,900 | N/A |
| Net Income Continuous | -127,300 | -263,300 | -112,000 | -27,200 | N/A |
| Net Income | $-127,300 | $-263,300 | $-112,000 | $-27,200 | $N/A |
| EPS Basic Total Ops | -1.41 | -3.18 | -1.39 | -0.35 | N/A |
| EPS Basic Continuous Ops | -1.41 | -3.18 | -1.39 | -0.35 | N/A |
| EPS Diluted Total Ops | -1.41 | -3.18 | -1.39 | -0.35 | N/A |
| EPS Diluted Continuous Ops | -1.41 | -3.18 | -1.39 | -0.35 | N/A |
| EPS Diluted Before Non-Recurring Items | -0.29 | -0.76 | -0.67 | -0.35 | -0.35 |
| EBITDA(a) | $-5,700 | $-195,500 | $-71,000 | $-125,900 | $N/A |